All in-person runners will be required to provide proof of a complete COVID-19 vaccination seriesLearn more.
  • Slider Image

COVID-19 Policies for 2021 Philadelphia Marathon Weekend

Overview

(Note: Updated on October 12 with clarification on Moderna and international options)

The 2021 Philadelphia Marathon Weekend is scheduled to return to the streets of Philadelphia on Saturday, November 20 and Sunday, November 21. The information on this page reflects event policies that align with evolving guidance and requirements from the City of Philadelphia.

In accordance with guidance provided by the Philadelphia Department of Public Health, all in-person runners at all 2021 Philadelphia Marathon Weekend events will be required to provide proof of a complete COVID-19 vaccination series prior to race weekend. Proof of a negative COVID-19 PCR or rapid antigen test will not be considered acceptable documentation for participation. As a result of this vaccination requirement, the Dunkin’ Munchkin Run (Kid’s Run) has been cancelled for 2021.

Proof of vaccination is necessary to ensure athlete safety and public health because runners cannot be expected and will not be required to wear face masks while running. Athletes will be required to wear face masks in other areas near the start and finish line areas in accordance with established City masking guidelines. Participating athletes will be permitted to remove face masks once inside runner corrals while warming up, and while on the racecourse. All race day staff, volunteers, and spectators will be required to wear a face mask while inside of the start/finish area footprint. Masks will be made available onsite as needed.

"The Philadelphia Marathon Weekend leadership team have been and will continue to work closely with the Philadelphia Department of Public Health throughout the planning process for the 2021 Philadelphia Marathon Weekend events," said Dave Wilson, Deputy Managing Director for General Services, Arts and Events. "We believe these new guidelines will provide safety and protection for our staff, athletes, volunteers and partners."

Participation requirements

All in-person runners must complete a World Health Organization-certified vaccination series two weeks prior to race day. For participation in the Rothman Orthopaedics 8K and/or the Dietz & Watson Philadelphia Half-Marathon, the vaccination series must be completed no later than Saturday, November 6, 2021. For participation in the AACR Philadelphia Marathon, the vaccination series must be completed no later than Sunday, November 7, 2021.

Runners must provide proof of vaccination prior to pick-up/delivery of race bibs and other materials. Instructions for uploading vaccination cards/documentation ahead of time (preferred method) will be emailed to registrants and published online at our website.

Runners may elect to bring an original paper copy, digital copy, photocopy, or photo of their vaccination proof to the Philadelphia Marathon Weekend Expo on at the Pennsylvania Convention Center on Friday, November 19 or Saturday, November 20, 2021. Staff will be on hand at the Convention Center to verify documentation and distribute bibs and race materials.

All attendees are accountable for their own actions and behavior prior to the event, during travel and while participating in event-related activities and other activities around Philadelphia during the event weekend.

Failure to follow these policies and guidelines may result in denial of participation in or entry to some or all events.

COVID-19 Vaccination Information

Runners who are NOT fully vaccinated at this time are encouraged to reference the tables below to determine which vaccination is AVAILABLE to meet the deadlines outlined above.

This section is for those runners who NEED to be vaccinated or are in the process of full vaccination.

Rothman Orthopaedics 8K and/or Dietz & Watson Philadelphia Half-Marathon (November 20, 2021)

Vaccine Type: Moderna

Last date for first dose: October 9, 2021
Last date for second dose: November 6, 2021

Vaccine Type: Pfizer

Last date for first dose: October 16, 2021
Last date for second dose: November 6, 2021

Vaccine Type: Johnson & Johnson (J&J)

Last date for first dose: November 6, 2021
Last date for second dose: N/A (Single dose)

AACR Philadelphia Marathon (November 21, 2021)

Vaccine Type: Moderna

Last date for first dose: October 10, 2021
Last date for second dose: November 7, 2021

Vaccine Type: Pfizer

Last date for first dose: October 17, 2021
Last date for second dose: November 7, 2021

Vaccine Type: Johnson & Johnson (J&J)

Last date for first dose: November 7, 2021
Last date for second dose: N/A (Single dose)

All participants must by fully vaccinated by November 6 for Rothman Orthopaedics 8K and/or Dietz & Watson Philadelphia Half-Marathon and November 7 for AACR Philadelphia Marathon.

For domestic U.S. participants:

The CDC offers an online tool to find vaccination sites/clinics by vaccine type.

The Philadelphia Department of Public Health offers additional guidance for vaccination sites online.

All international travelers should consult the list of approved vaccinations on the World Health Organization site at www.who.int.

For Canadian participants: Mixed doses will be acceptable.

Refunds/Deferrals

As a result of the vaccination requirement for 2021 Philadelphia Marathon Weekend, the Dunkin’ Munchkin Run (Kid’s Run) has been cancelled for 2021. Dunkin’ Munchkin Run (Kid’s Run) registrants will be offered the option of a deferment to 2022 or 2023 at no additional cost, or a partial refund that would not include administrative costs and service fees.

Registrants for the Rothman Orthopaedics 8K, Dietz & Watson Philadelphia Half-Marathon, AACR Philadelphia Marathon, or any Challenge races will be offered options for deferment, transfer to a virtual race or partial refund.

Further guidance will be provided as soon as possible.

In the event that a registered runner tests positive for COVID-19 prior to a race and is unable to participate, that individual will be offered the option of transferring to the virtual run or a deferment to 2022 or 2023 at no additional cost.

Health policy

Creating a safe environment for race weekend is everyone’s responsibility. You can contribute to the overall safety of the event by reviewing and following the health and safety procedures described below.

If you feel sick or experience symptoms of COVID-19 (e.g., a fever of 100.4F or higher, cough, shortness of breath or difficulty breathing, chills, repeated shaking, muscle pain/achiness, headache, sore throat, loss of taste or smell, nasal congestion, runny nose, vomiting, diarrhea, fatigue or any other symptoms associated with COVID-19 identified by the Centers for Disease Control and Prevention) you should self-isolate and not participate in event activities or enter event venues while symptomatic, and you should defer or move into a virtual event.

If you have tested positive or been exposed to someone who has tested positive for COVID-19 within 14 days of the event, please do not participate in or attend the event. Registered participants who test positive for COVID-19 within 14 days of the event should see our deferral or virtual options.

Vaccination proof

Individuals should be prepared to display proof of identification with a government issued ID (driver’s license or passport) along with proof of vaccination in the form of an immunization record issued by a government entity or accredited healthcare facility.

Acceptable forms of proof include the original document, a photocopy, or digital image on a smartphone, tablet or other device. The immunization record must include the name of the individual matching their government issued photo identification, the date of vaccination(s), and a serial number or batch number of the dose given.

This policy recognizes COVID-19 vaccines fully approved or authorized for emergency use by the Food and Drug Administration Opens a Dialog (FDA) and the World Health Organization (WHO).

If a person received a vaccine not approved or recognized for emergency use by the FDA or the WHO, they will not be permitted to race.

Philadelphia Marathon Weekend Expo

The 2021 Philadelphia Marathon Weekend Expo will take place at the Pennsylvania Convention Hall (Hall F) on Friday, November 19 and Saturday, November 20, 2021. This year’s Expo will be open to runners only, and all attendees, staff and volunteers will be required to wear a face mask.

Runners must provide proof of vaccination prior to pick-up/delivery of race bibs and other materials. 

Instructions for uploading vaccination cards/documentation ahead of time (preferred method) will be emailed to registrants and published on our website.

As previously stated, runners may elect to bring an original paper copy, digital copy, photocopy or photo of their vaccination proof to the Philadelphia Marathon Weekend Expo at the Pennsylvania Convention Center on Friday, November 19 or Saturday, November 20, 2021.

Upon verification of proof, individuals will receive a tamper proof wristband which will act as identification that runners have cleared the screening process, and will allow entrance into race events for the remainder of the weekend.

Participants who receive their race materials in the mail will need to upload their proof of vaccination prior to items being mailed. Runners should present their secure wristband and bib at the security check points on race day and to enter the start line area. Further guidance will be provided as soon as possible.

The wristband must be worn continuously throughout race weekend and should not be removed. 

In the event the wristband is lost or damaged, individuals should be prepared to re-present their proof of full vaccination and ID to the information tent location outside the secure race zone on race day. 

The event will not grant exceptions to the above policy, including a runner having a bib.

Individuals who are unable to provide the appropriate documentation will not be granted access to the event, even if they have a bib.

There are no plans to administer COVID-19 vaccinations or tests at the Expo at this time.